KATIE GREEN: Open Payments
NPI 1790492916 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 34 payments from 18 companies in 2025. Trend: 2023 $516 · 2024 $571 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $182 |
| Boston Scientific Corporation | 2 | $75 |
| PFIZER INC. | 3 | $53 |
| Tris Pharma Inc | 2 | $48 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Amgen Inc. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
Products named: VRAYLAR, AMS 700, UBRELVY, Dyanavel XR, Jornay PM, CAPLYTA, SHINGRIX, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
